Health Dictionary Find a Doctor

Gout

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Synonyms and keywords: Urate crystal arthropathy; uric acid crystal deposition in joint; gouty arthritis; podagra

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

Gout is a common arthritis caused by deposition of monosodium urate crystals within joints after chronic hyperuricaemia. It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men. Epidemiological data are consistent with a rise in prevalence of gout. Diet and genetic polymorphisms of renal transporters of urate seem to be the main causal factors of primary gout. Gout and hyperuricaemia are associated with hypertension, diabetes mellitus, metabolic syndrome, and renal and cardiovascular diseases. Non-steroidal anti-inflammatory drugs and colchicine remain the most widely recommended drugs to treat acute attacks. Oral corticosteroids could be an alternative to these drugs. Interleukin 1beta is a pivotal mediator of acute gout and could become a therapeutic target. When serum uric acid concentrations are lowered below monosodium urate saturation point, the crystals dissolve and gout can be cured. Patient education, appropriate lifestyle advice, and treatment of comorbidities are an important part of management of patients with gout.






Gout, otherwise called as metabolic arthritis is a congenital disorder of Uric acid metabolism. In this condition, monosodium urate or uric acid crystals are deposited on the articular cartilage of joints, tendons and surrounding tissues due to elevated concentrations of uric acid in the blood stream. This provokes an inflammatory reaction of these tissues. These deposits often increase in size and burst through the skin to form sinuses discharging a chalky white material.

Gout historical perspective

  • Gout was first described by Egyptians in 2640 BC.
  • Hippocrates described podagra in 5th century BC as the unwalkable disease.
  • Galen described the monosodium urate crystal deposition following long standing hyperuricemia as Tophi. He described gout as a discharge of the four humors of the body in unbalanced amounts into the joints.
  • The word Gout was first used in 1200s AD by Dominican monk Randolphus of Bocking and was derived from the Latin word ‘Gutta’.
  • Aulus Cornelius Celsus discovered many symptoms of gout.

Pathophysiology

Gout occurs when mono-sodium urate crystals form on the articular cartilage of joints, on tendons, and in the surrounding tissues. Purine metabolism gives rise to uric acid, which is normally excreted in the urine. Defects in the kidney may cause uric acid to build up in the blood, leading to hyperuricemia, and the subsequent formation of gout crystals.

Differentiating Gout from other Diseases

Gout needs to be differentiated from other diseases such as cellulitis, rheumatoid arthritis, septic arthritis and sarcoidosis as they present with similar symptoms.

Epidemiology and Demographics

Gout affects men in age group 40-50 years. It is more common in people from the Pacific Islands, and New Zealand. In the United States, gout is twice as prevalent in African American males as it is in Caucasians.

Risk Factors

Several factors may put a person at risk for developing gout. These include the presence of; hypertension, diabetes, hypercholesterolemia, obesity, and alcohol abuse. Certain medications may also put a person at a higher risk for developing gout.

Prognosis

The prognosis of gout is good if it is treated early, and if the person maintains a healthy lifestyle with modification of their individual risk factors.

Diagnosis

Symptoms

The classic picture of an acute gouty attack, is sudden, excruciating, unexpected and burning pain. There will also be swelling, redness, warmth, and stiffness in the joint. In approximately 75% of first episodes, gout usually attacks the big toe.

Laboratory Findings

A definitive diagnosis of gout is made from light microscopy of the fluid aspirated from the joint. The fluid demonstrates intracellular negatively bi-refringent monosodium urate crystals and polymorphonuclear leukocytes in the synovial fluid. Although hyperuricemia is a common feature of gout, a high uric acid level does not necessarily mean a person will develop gout.

X-ray

An x-ray is done when gout is suspected to rule out other abnormalities of the bone that may be causing the pain. Most commonly in gout, the x-ray will show no abnormalities, or a small amount of soft tissue swelling.

Treatment

Medical Therapy

The first goal of therapy when treating gout, is pain relief. This can be acheived with NSAIDs, and oral or intra-articular glucocorticoids. If colchicine is given, it should be taken within the first 12 hours of the attack. Other, less standard methods of treatment include the use of hemorrhoidal ointment, ice, increasing mobility, and acetazolamide.

Surgery

For extreme cases of gout, surgery may be necessary to remove large tophi and correct joint deformity.

Secondary Prevention

There are several methods used to prevent a re-occurrence of gout. Dietary changes include reducing the intake of foods that increase the levels of purine in blood, such as protein and alcohol. Several foods, and vitamin C have been thought to decrease the levels of purine in the blood. Modification of the risk factors for gout has been shown to also be beneficial in reducing the reoccurrence of gout. There are medications which can increase the excretion of uric acid, and reduce uric acid levels through other mechanisms.

References

Template:WH Template:WS

Historical Perspective


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

  • Gout was first described by Egyptians in 2640 BC.
  • Hippocrates described podagra in 5th century BC as an unwalkable disease.
  • Galen described the monosodium urate crystal deposition following long-standing hyperuricemia as Tophi. He described gout as a discharge of the four humors of the body is unbalanced amounts into the joints.
  • The word Gout was first used in 1200s AD by Dominican monk Randolphus of Bocking and was derived from the Latin word ‘Gutta’.
  • Aulus Cornelius Celsus discovered many symptoms of gout.

Historical Perspective

Antoine van Leeuwenhoek contributed to the field by describing the appearance of uric acid crystals in 1679., https://en.wikipedia.org/wiki/Gout#/media/File:Anthonie_van_Leeuwenhoek_(1632-1723)._Natuurkundige_te_Delft_Rijksmuseum_SK-A-957.jpeg

Gout was first identified by Egyptians around 2640 BC[1]. This is one of the most studied diseases do far with more than millions[2] of people still suffering from the disease until today. Out of them, the males are affected the most. The scientist has a lot to offer regarding this chronic and debilitating disease. Although it was first recognized by Egyptians the first clinical description of the disease came from Hippocrates ( 460-370)[3]. After a century later there is another scientist named Cappadocian gave a proposal that the gout disease is caused by the toxin in the blood. Which later on given the name of Uric acid in further studies.

Naming the disease

The first person to name the disease was “Randolph of Bocking” in the early 1200s[1]. The term is usually derived from the Latin word gutta or drop. Till day the variation of terms is seen in different languages all over the world. In English “gout”, In French ” goutte” and in the Italian language it means ” gotta” and in German named as “gicht”

Understanding the disease

In the seventeenth century the scientist “Thomas Sydenham” was the first person to study the aspects of Gout disease in terms of Acute or chronic aspects. He also helps in explaining and differentiating gout from the other diseases related to different forms of arthritis.

The tophi that are uric acid crystal deposits those were fist identified, studied, and described these as tiny needle-like particles under the microscope by the famous scientist “Anton Von Leeuwenhoek”.

This was later identified as urate crystals by a Swedish scientist named “Carl Scheele”.

Advance Work-up

The next remarkable contribution to the study of gout was made by Alfred Baring Garrod. He conducted some great experiments and eye-opening research where he demonstrated the relation between high levels of uric acid in the bloodstream and the development of gout.

Search for to control the disease

Different treatment and management theories are studied and implemented to manage the Gout over years but the Early treatment options that came from Hippocrates included minimal water and counterirritation that is basically scorching the veins near the joint affected. Bloodletting is also one of the ancient techniques used at that time.

Introducing the colchicine

Although colchicine was used in ancient times for more than 2000 years it was first used for the treatment of Gout Alexander of Tralles in around 600 AD. Then due to any reason, this was out of use for hundreds of years before re-discovering it for use by an Australian physician Baron Anton de Stock in 1700. The most noticeable user for the colchicine was Benjamin Franklin. Till today the colchicine therapy is used to prevent gout flares and played a huge role in the management of patients with Gout.

References

  1. 1.0 1.1 Nuki G, Simkin PA (2006). “A concise history of gout and hyperuricemia and their treatment”. Arthritis Res. Ther. 8 Suppl 1: S1. doi:10.1186/ar1906. PMC 3226106. PMID 16820040.
  2. Zhu Y, Pandya BJ, Choi HK (October 2011). “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008”. Arthritis Rheum. 63 (10): 3136–41. doi:10.1002/art.30520. PMID 21800283.
  3. Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N (March 2019). “Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout”. Arthritis Care Res (Hoboken). 71 (3): 427–434. doi:10.1002/acr.23607. PMC 6252290. PMID 29799677.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

Hyperuricemia is considered a multifactorial metabolic disorder in the general population. The levels of uric acid are influenced by the use of drugs, medications, renal impairment, and Alcohol also. The excess of uric acid levels gets deposited in the joints, kidneys, and a lot of tissue leading to clinical manifestations such as tophi, nephrolithiasis along the presence of urate nephropathy. Decreased excretion of uric acid contributes the maximum towards the development of Hyperuricemia. Along with the minimal contribution from other factors like increased production and increased consumption of foods rich in uric acid. The deposits in the joints, skin, and other tissues compromise the function of organs and resulting in the abnormal configuration of joint with funv=ctional limitation along with the presence of clinical signs in the form of pain and swelling.

Pathophysiology

In terms of pathophysiological classification, we can categorize gout into 2 main types

1) Primary gout: Mainly hereditary or related to enzymatic abnormalities

2) Secondary Gout: Secondary to other reasons like drugs, renal insufficiency, dietary or related to malignancy

Pathophysiological factors for the development of Gout https://www.pinterest.com/pin/129971139223442993/?nic_v2=1a30H8fPo


The pathophysiology[1][2]of Gout mainly relates to hyperuricemia. Greater is the degree of hyperuricemia greater is the likelihood of developing Gout[3].

Numerous reasons can lead to the development of an increase in the level of uric acids[4][5]:

  • Enhanced or increased purine uptake.
  • Decreased excretion of uric acid
  • Increased production of uric acid
  • Etiology in a lot of cases with rising uric acid levels is still unknown.


Increased intake

The increased uptake is mainly related to

  • Increases intake of purine-rich food substances by the patient such as
    • Asparagus, meat broths, mushrooms, liver, kidney, sweetbreads.
    • The increased intake of all of these substances can increase the risk of accumulation of more and more purines ultimately resulting in the excess of uric acid.
  • Beer is also particularly rich in guanosine which is a purine nucleotide.
Numerous factors and conditions responsible for the development of gout
Pathophysiology of Gout https://www.researchgate.net/figure/Key-checkpoints-in-gout-pathogenesis_fig1_44601699


Increased production

The increased production is mainly

  • Increase in turn over of cells like in various hematological conditions such as Hemolytic anemia, leukemia, and lymphoma.
  • Conditions associated with an increased rate of cell proliferation and cell death.
    • Cytotoxic therapy
    • Radiation
    • Psoriasis[6]
  • Obesity – As the urate production is directly proportional to the body surface area


Decreased/Reduced renal excretion

This is the most common cause of hyperuricemia. Various factors responsible for its reduced elimination are:

  • Hereditary
  • Compromised renal function ( Reduced GFR)
  • On Diuretics[8]
  • Alcohol intake[9]
    • The lactic acid blocks the excretion of urate from the renal tubules. Alcohol induces the purine metabolism in the liver and increases the formation of lactic acid and
    • Alcohol also directly stimulates the synthesis of urate by the liver
  • Drugs like cyclosporine that are toxic to the renal tubules leads to the decreased elimination of uric acid and ultimately resulting in the urate retention.



Gross and Microscopic Pathology

Kidney: Uric Acid Deposition: Gross, an excellent example of gouty nephropathy with deposits and excavation in pyramids
Kidney: Papillary Necrosis: Gross, yellow foci in pyramids, a gout kidney
Gout (Needles, no birefringence, monosodium urate)
Skin: Tophus: Micro med mag H&E uric acid deposits with giant cells. Easily recognizable as gout or uric acid tophus

Sources

Copyleft images obtained courtesy of Charlie Goldberg, M.D., UCSD School of Medicine and VA Medical Center, San Diego, CA) Images courtesy of Professor Peter Anderson DVM Ph.D. and published with permission © PEIR, the University of Alabama at Birmingham, Department of Pathology

References

  1. Milas-Ahić J, Prus V, Visević R (2012). “[Pathophysiology of gout]”. Reumatizam. 59 (2): 89–92. PMID 23745463.
  2. Abhishek A, Roddy E, Doherty M (February 2017). “Gout – a guide for the general and acute physicians”. Clin Med (Lond). 17 (1): 54–59. doi:10.7861/clinmedicine.17-1-54. PMC 6297580. PMID 28148582.
  3. Gustafsson D, Unwin R (July 2013). “The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality”. BMC Nephrol. 14: 164. doi:10.1186/1471-2369-14-164. PMC 3750299. PMID 23895142.
  4. Dalbeth N, Merriman TR, Stamp LK (October 2016). “Gout”. Lancet. 388 (10055): 2039–2052. doi:10.1016/S0140-6736(16)00346-9. PMID 27112094.
  5. Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P (June 2018). “Crystal arthritides – gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology”. Z Gerontol Geriatr. 51 (4): 453–460. doi:10.1007/s00391-017-1197-3. PMID 28233117.
  6. Hu SC, Lin CL, Tu HP (March 2019). “Association between psoriasis, psoriatic arthritis and gout: a nationwide population-based study”. J Eur Acad Dermatol Venereol. 33 (3): 560–567. doi:10.1111/jdv.15290. PMID 30317664.
  7. Torres RJ, Puig JG (December 2007). “Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome”. Orphanet J Rare Dis. 2: 48. doi:10.1186/1750-1172-2-48. PMC 2234399. PMID 18067674.
  8. Ben Salem C, Slim R, Fathallah N, Hmouda H (May 2017). “Drug-induced hyperuricaemia and gout”. Rheumatology (Oxford). 56 (5): 679–688. doi:10.1093/rheumatology/kew293. PMID 27498351.
  9. Towiwat P, Li ZG (June 2015). “The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout”. Int J Rheum Dis. 18 (5): 495–501. doi:10.1111/1756-185X.12622. PMID 26082349.

Template:WH Template:WS

Differentiating Gout from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

Gout needs to be differentiated from other Crystal arthropathies and also from the diseases that present with similar symptoms. List of diseases that present with similar symptoms include cellulitis, Rheumatoid arthritis, trauma, Septic arthritis and tophaceous gout from Osteomyelitis, Dactylitis and other Autoimmune Arthritis like Reactive arthritis, sarcoidosis. Gout must also be differentiated from other causes of rash and Arthritis. Synovial fluid aspiration and analysis including Gram staining,culture and different types of microscopic examination is the Diagnostic for differentiating gout from other diseases. X-rays when combined with effective History and Physical examination also help in differentiating diseases.

Differentiating Gout from other Diseases

Gout must be differentiated from other causes of acute and chronic inflammatory Joint Disease such as Pseudogout or Calcium pyrophosphate Dihydrate deposition disease, Calcium apatite deposition disease.

gout pseudogout Calcium apatite deposition disease Calcium Oxalate deposition disease
Cause Urate crystal deposition in joints Calcium Pyrophosphate dihydrate deposition in joints Calcium apatite deposition in joints Calcium oxalate deposition in joints
Most frequently involved First metatarsal bone Knee-joint Shoulder-joint { Milwaukee Shoulder} in elderly Shoulder Joint
Diagnosis Needle shaped negatively birefringent Monosodium urate crsytals on synovial fluid analysis Blunt rods, rhomboid shaped Calcium pyrophosphate dihydrate positively birefringent crsytals on Synovial fluid analysis Calcium apatite crystals that stains purplish on Wright’s stain and red with Alizarin. Definitive diagnosis needs Electron microscopy. Extremely rare. Calcium oxalate depositions seen in the joints .
Treatment Analgesia, NSAIDs, Colchicine, xanthine oxidaseXanthine inhibitors and Uricosuric drugs. NSAIDs, Intravascular Glucocorticosteroids. NSAIDS, repeat Aspiration of affected joints, and rest. Identifying the etiology of primary vs secondary oxalosis and treating the cause.

Certain diseases can present with similar symptoms like

Gout must be differentiated from other diseases that cause bone pain, edema, and erythema.

Disease Findings
Soft tissue infection
(Commonly cellulitis)
History of skin warmness, swelling and erythema. Bone probing is the definite way to differentiate them.[1][2]
Osteonecrosis
(Avascular necrosis of bone)
Previous history of trauma, radiation, use of steroids or biphosphonates are suggestive to differentiate osteonecrosis from ostemyelitis.[3][4]
MRI is diagnostic.[5][6]
Charcot joint Patients with Charcot joint commonly develop skin ulcerations that can in turn lead to secondary osteomyelitis.
Contrast-enhanced MRI may be diagnostically useful if it shows a sinus tract, replacement of soft tissue fat, a fluid collection, or extensive marrow abnormalities. Bone biopsy is the definitive diagnostic modality.[7]
Bone tumors May present with local pain and radiographic changes consistent with osteomyelitis.
Tumors most likely to mimic osteomyelitis are osteoid osteomas and chondroblastomas that produce small, round, radiolucent lesions on radiographs.[8]
Gout Gout presents with joint pain and swelling. Joint aspiration and crystals in synovial fluid is diagnostic for gout.[9]
SAPHO syndrome
(Synovitis, acne, pustulosis, hyperostosis, and osteitis)
SAPHO syndrome consists of a wide spectrum of neutrophilic dermatosis associated with aseptic osteoarticular lesions.
It can mimic osteomyelitis in patients who lack the characteristic findings of pustulosis and synovitis.
The diagnosis is established via clinical manifestations; bone culture is sterile in the setting of osteitis.
Sarcoidosis It involves most frequently the pulmonary parenchyma and mediastinal lymph nodes, but any organ system can be affected.
Bone involvement is often bilateral and bones commonly affected include the middle and distal phalanges (producing “sausage finger”), wrist, skull, vertebral column, and long bones.
Langerhans’ cell histiocytosis The disease usually manifests in the skeleton and solitary bone lesions are encountered twice as often as multiple bone lesions.
The tumours can develop in any bone, but most commonly originate in the skull and jaw, followed by vertebral bodies, ribs, pelvis, and long bones.[10]

Gout must be differentiated from other causes of rash and arthritis[11][12][13]

Disease Findings
Nongonococcal septic arthritis
  • Presents with an acute onset of joint swelling and pain (usually monoarticular)
  • Culture of joint fluid reveals organisms
Acute rheumatic fever
  • Presents with polyarthritis and rash (rare presentation) in young adults. Microbiologic or serologic evidence of a recent streptococcal infection confirm the diagnosis.
  • Poststreptococcal arthritis have a rapid response to salicylates or other antiinflammatory drugs.
Syphilis
  • Presents with acute secondary syphilis usually presents with generalized, pustular lesions at the palms and soles with generalized lymphadenopathy
  • Rapid plasma reagin (RPR), Venereal Disease Research Laboratory (VDRL) and Fluorescent treponemal antibody absorption (FTA-ABS) tests confirm the presence of the causative agent.
Reactive arthritis (Reiter syndrome)
  • Musculoskeletal manifestation include arthritis, tenosynovitis, dactylitis, and low back pain.
  • Extraarticular manifestation include conjunctivitis, urethritis, and genital and oral lesions.
  • Reactive arthritis is a clinical diagnosis based upon the pattern of findings and there is no definitive diagnostic test
Hepatitis B virus (HBV) infection
  • Presents with fever, chills, polyarthritis, tenosynovitis, and urticarial rash
  • Synovial fluid analysis usually shows noninflammatory fluid
  • Elevated serum aminotransaminases and evidence of acute HBV infection on serologic testing confirm the presence of the HBV.
Herpes simplex virus (HSV)
  • Genital and extragenital lesions can mimic the skin lesions that occur in disseminated gonococcal infection
  • Viral culture, polymerase chain reaction (PCR), and direct fluorescence antibody confirm the presence of the causative agent.
HIV infection
  • Present with generalized rash with mucus membrane involvement, fever, chills, and arthralgia. Joint effusions are uncommon
Gout and other crystal-induced arthritis
  • Presents with acute monoarthritis with fever and chills
  • Synovial fluid analysis confirm the diagnosis.
Lyme disease
  • Present with erythema chronicum migrans rash and monoarthritis as a later presentation.
  • Clinical characteristics of the rash and and serologic testing confirm the diagnosis.

References

  1. Bisno AL, Stevens DL (1996). “Streptococcal infections of skin and soft tissues”. N. Engl. J. Med. 334 (4): 240–5. doi:10.1056/NEJM199601253340407. PMID 8532002.
  2. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014). “Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America”. Clin. Infect. Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.
  3. Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, Ochiai N, Takahashi K (2011). “Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study”. Rheumatology (Oxford). 50 (11): 2023–8. doi:10.1093/rheumatology/ker277. PMID 21865285.
  4. Slobogean GP, Sprague SA, Scott T, Bhandari M (2015). “Complications following young femoral neck fractures”. Injury. 46 (3): 484–91. doi:10.1016/j.injury.2014.10.010. PMID 25480307.
  5. Amanatullah DF, Strauss EJ, Di Cesare PE (2011). “Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management”. Am J. Orthop. 40 (9): E186–92. PMID 22022684.
  6. Etienne G, Mont MA, Ragland PS (2004). “The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head”. Instr Course Lect. 53: 67–85. PMID 15116601.
  7. Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP (2006). “Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics”. Radiology. 238 (2): 622–31. doi:10.1148/radiol.2382041393. PMID 16436821.
  8. Lovell, Wood (2014). Lovell and Winter’s pediatric orthopaedics. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-1605478142.
  9. Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW (2010). “Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis”. Arthritis Rheum. 62 (11): 3237–48. doi:10.1002/art.27667. PMC 2970687. PMID 20662061.
  10. Picarsic J, Jaffe R (2015). “Nosology and Pathology of Langerhans Cell Histiocytosis”. Hematol. Oncol. Clin. North Am. 29 (5): 799–823. doi:10.1016/j.hoc.2015.06.001. PMID 26461144.
  11. Rompalo AM, Hook EW, Roberts PL, Ramsey PG, Handsfield HH, Holmes KK (1987). “The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis”. Arch Intern Med. 147 (2): 281–3. PMID 3101626.
  12. Rice PA (2005). “Gonococcal arthritis (disseminated gonococcal infection)”. Infect Dis Clin North Am. 19 (4): 853–61. doi:10.1016/j.idc.2005.07.003. PMID 16297736.
  13. Bleich AT, Sheffield JS, Wendel GD, Sigman A, Cunningham FG (2012). “Disseminated gonococcal infection in women”. Obstet Gynecol. 119 (3): 597–602. doi:10.1097/AOG.0b013e318244eda9. PMID 22353959.

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

Gout affects men in the age group of 40-50 years. It is more common in people from the Pacific Islands and New Zealand. In the United States, gout is twice as prevalent in African American males as it is in Caucasians[1]. The American College of Rheumatology/European League Against Rheumatism Collaborative Initiative has noted that gout is the most common form of inflammatory arthritis, with a prevalence of 3.9% in the United States[2]

Epidemiology and demographics

References

  1. Roberts-Thomson R, Roberts-Thomson P (1999). “Rheumatic disease and the Australian aborigine”. Ann Rheum Dis. 58 (5): 266&ndasgh, 70. PMID 10225809.
  2. Rheumatology Therapeutics Medical Center. “What Are the Risk Factors for Gout?”. Retrieved 2007-01-26.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivam Singla, M.D.[2]

Overview

Gout is a disease related to joints that usually develops in patients with high levels of uric acid. The uric acid precipitates as needle-like crystals in the tissues mainly in the joints and other articular tissues resulting in sudden severe episodic pain, redness. warmth and swelling. There are a number of factors[1] that can lead to the development of gout. Gout is seen in about 4% of people in America. It is more common in men than in women with a ratio of nearly 3:1. There are numerous risk factors like Genes, Gender, and age, Diet, Obesity, Alcohol consumption, Medical condo=itions, and medication use. All the former mentioned risk factors increase the risk of developing gout in the patients.

Risk Factors

Gout is a disease related to joints that usually develops in patients with high levels of uric acid. The uric acid precipitates as needle-like crystals in the tissues mainly in the joints and other articular tissues resulting in sudden severe episodic pain, redness. warmth and swelling. There are a number of factors[1][2] that can lead to the development of gout. Gout is seen in about 4% of people in America. It is more common in men than in women with a ratio of nearly 3:1. There are numerous risk factors for the development of out and can increase the chances of the patient developing the painful joint disease.

Genes

The studies conducted at MRC Human Genetic units proved that the patients who suffer from usually have a positive family history of gout. And in these patients, the most important factor noted is the presence of a gene variant that is linked to the low levels of uric acid excretion.

Gender and Age

Gout predominance is seen most commonly in men. The theory proposed by a various scientist is that the higher levels of estrogens in females play a protective role during their reproductive age group period and usually increases after the occurrence of menopause in females and matches the risk equivalent to men’s for that age group.

Diet

Diets such as Seafood consumption or consumption of a diet rich in fructose beverages have been found to be linked to the higher levels of uric acid and in turn, leading to the development of gout. The higher purine content in the seafood gets broken down to uric acid and in turn, leads to the production of gout.

Obesity

Uric acid excretion is thought to be dependent on the body surface area also. so In an obese person, the body is more likely to produce more uric acid and it can get worse if the patient also has underlying renal abnormality present along with it.

Alcohol Consumption

Alcoholic drinks especially beer are high in purine content and thus contribute the greatest to the development of gout. Even the quantity of alcohol intake also plays a huge in the development of gout. More than 2 drinks a day is also a risk factor for the development of gout. So it is always advisable to cut down the alcohol drinking to the minimal and best is to stop it completely, if possible.

Medical Conditions

The medical conditions like High Blood pressure[3], high blood sugar, heart, and kidney diseases contribute to the greatest extent in the development of gout.

Medications

A lot of Medications are associated with the risk of developing gout. The most common amongst them are Diuretics and also the drugs that affect the immune system increase the risk of developing gout. So it is always advisable to discuss with the primary care physician before starting any other medication.

Recent Surgery or Trauma

Any surgery can increase the risk of developing gout with more correlation to joint surgery or accidents.

References

  1. Lin KC, Lin HY, Chou P (June 2000). “The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study”. J Rheumatol. 27 (6): 1501–5. PMID 10852278.
  2. “Risk Factors for Gout”.
  3. Lin KC, Tsao HM, Chen CH, Chou P (June 2004). “Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia”. J Rheumatol. 31 (6): 1152–8. PMID 15170929.
Screening

Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.

Overview

The prognosis of gout is good if it is treated early, and if the person maintains a healthy lifestyle with modification of their individual risk factors.

Prognosis

Generally, the prognosis of gout is good. It depends on:

  • Whether the patient is treated early
  • Whether the patient maintains a healthy lifestyle.

References

Template:WH Template:WS

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies


To go back to the main page, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Sumanth Khadke, MD[2]

Overview

In general, diagnosis (plural diagnoses) has two distinct dictionary definitions. The first definition is “the recognition of a disease or condition by its outward signs and symptoms”, while the second definition is “the analysis of the underlying physiological/biochemical cause(s) of a disease or condition”.

Diagnosis covers a broad spectrum, or spectra, of testing in some form of analysis; collective reasoning using such tests is called the method of diagnostics, leading then to the results of those tests by ideal (ethics) would then be considered a diagnosis, but not necessarily the correct one.

In medicine, diagnosis or diagnostics is the process of identifying a medical condition or disease by its signs, symptoms, and from the results of various diagnostic procedures. The conclusion reached through this process is called a diagnosis. The term “diagnostic criteria” designates the combination of symptoms which allows the doctor to ascertain the diagnosis of the respective disease.

Typically, someone with abnormal symptoms will consult a physician, who will then obtain a history of the patient‘s illness and examine him for signs of disease. The physician will formulate a hypothesis of likely diagnoses and in many cases will obtain further testing to confirm or clarify the diagnosis before providing treatment.

Medical tests commonly performed are measuring blood pressure, checking the pulse rate, listening to the heart with a stethoscope, urine tests, fecal tests, saliva tests, blood tests, medical imaging, electrocardiogram, hydrogen breath test and occasionally biopsy.

The word diagnosis is derived from the Greek words dia which means “by”, and gnosis which means “knowledge”. The verb is diagnose and a person diagnosing could be considered a diagnostician.

Relationship of diagnosis to medical practice

A physician‘s job is to know the human body and its functions in terms of normality (homeostasis). The four cornerstones of diagnostic medicine, each essential for understanding homeostasis, are: anatomy (the structure of the human body), physiology (how the body works), pathology (what can go wrong with the anatomy and physiology) and psychology (thought and behavior). Once the doctor knows what is normal and can measure the patient’s current condition against those norms, she or he can then determine the patient’s particular departure from homeostasis and the degree of departure. This is called the diagnosis. Once a diagnosis has been reached, the doctor is able to propose a management plan, which will include treatment as well as plans for follow-up. From this point on, in addition to treating the patient’s condition, the doctor educates the patient about the causes, progression, outcomes, and possible treatments of his ailments, as well as providing advice for maintaining health.

It should be noted however, that medical diagnosis in psychology or psychiatry is problematic. Apart from the fact that there are differing theoretical views toward mental conditions and that there are few “lab” tests available for various major disorders (e.g., clinical depression), a causal analysis with respect to symptomatology and disorder/disease is not always possible. As a result, most if not all mental conditions, function as both symptoms as well as disorders. There are often functional descriptions provided for psychological disorders and these are vulnerable to circular reasoning due to the etiological fuzziness inherent of these diagnostic categories. (BDG, 2006)

Diagnostic procedure

Diagnosis is a fluid process in which the physician responds to information garnered from the patient and others, from a physical examination of the patient, and from medical tests performed upon the patient.

The doctor should consider the patient in his ‘well’ context rather than simply as a walking medical condition. This entails assessing the socio-political context of the patient (family, work, stress, beliefs), in addition to the patient’s physical body, as this often offers vital clues to the patient’s condition and its management.

The process of diagnosis begins when the patient consults the doctor and presents a set of complaints (the symptoms). If the patient is unconscious, this condition is the de facto complaint. The doctor then obtains further information from the patient himself (and from those who know him, if present) about the patient’s symptoms, his previous state of health, living conditions, and so forth.

Rather than consider the myriad diseases that could afflict the patient, the physician narrows down the possibilities to the illnesses likely to account for the apparent symptoms, making a list of only those conditions that could account for what is wrong with the patient. These are generally ranked in order of probability.

The doctor then conducts a physical examination of the patient, studies the patient’s medical record, and asks further questions as he goes, in an effort to rule out as many of the potential conditions as possible. When the list is narrowed down to a single condition, this is called the differential diagnosis, and provides the basis for a hypothesis of what is ailing the patient.

Unless the physician is certain of the condition present, further medical tests are performed or scheduled (such as medical imaging), in part to confirm or disprove the diagnosis but also to document the patient’s status to keep the patient’s medical history up to date. Consultations with other physicians and specialists in the field may be sought. If unexpected findings are made during this process, the initial hypothesis may be ruled out and the physician must then consider other hypotheses.

Despite all of these complexities, most patient consultations are relatively brief, because many diseases are obvious, or the physician’s experience may enable him to recognize the condition quickly. Another factor is that the decision trees used for most diagnostic hypothesis testing are relatively short.

Once the physician has completed the diagnosis, he explains the prognosis to the patient and proposes a treatment plan which includes therapy and follow-up (further consultations and tests to monitor the condition and the progress of the treatment, if needed), usually according to the guideline provided by the medical field on the treatment of the particular illness.

Treatment itself may indicate a need for review of the diagnosis if there is a failure to respond to treatments that would normally work.

History of medical diagnostics

The history of medical diagnosis began in earnest from the enlightened days of Hippocrates in ancient Greece but is far from perfect despite the enormous bounty of information made available by medical research including the sequencing of the human genome. The practice of diagnosis continues to be dominated by theories set down in the early 1900s.

Ancient Greece

Over two thousand years ago, Hippocrates recorded the association between disease and heredity. In similar fashion, Pythagoras noted the association between metabolism and heredity (allergy to Fava beans). The medical community, however, has only recently acknowledged the importance of genetics and its relevance to mainstream medicine.

The Oslerian ideal

The ideals of William Osler who transformed the practice of medicine in the early 1900s were based on the principles of the diagnosis and treatment of disease. According to Osler, the functions of a physician were to be able to identify disease and its manifestations, understand its mechanisms, how it may be prevented and how it may be cured. For his medical students he believed that the best textbook was the patient himself – analysis of morbid anatomy and pathology were the keys. The Oslerian ideal continues today, as the basis of the Doctor’s strategy is, “What disease does this patient have and what is the best way for treatment?” The emphasis is on the classification of the disease in order to use the remedies available for its effects to be reversed or ameliorated. The human being in question is representative of a class of people with this type of disease whereas the biological individuality of this person is not given any great weight.

Garrod’s view

The successor to William Osler as Regius Professor at Oxford was Archibald Garrod. Garrod echoed the observations of his Greek counterparts of two millennia ago, …our chemical individualities are due to our chemical merits as well as our chemical shortcomings; and it is more nearly true to say that the factors which confer upon us our predispositions to and immunities from various mishaps which are spoken of as diseases, are inherent in our very chemical structure; and even in the molecular groupings which confer upon us our individualities, and which went into the making of the chromosomes from which we sprang. Considering that the time that he formulated these ideas were the early 1900’s, and the knowledge of DNA encoding genes that in turn encoded proteins responsible for bodily structure and functions not being discovered until some fifty years later it took some time before medicine could fully appreciate the fundamental importance of his concept of diagnosis.

Present-day Oslerian practice

Whereas Osler laid the founding principles by which medicine should be practiced, Garrod placed these principles in a greater context of a chemical individuality that is inherited and is subject to the mechanisms of evolutionary selection. The Oslerian ideal of medical practice continues to dominate medical philosophy today. The patient is a collective of symptoms to be characterized and analyzed algorithmically in order to draw a diagnosis and subsequently produce a strategy of treatment. Medicine is about problems based solutions. In keeping with this philosophy, today’s pathology reports provide a momentary snapshot of the patient’s biochemical profile, highlighting the end result of the disease process.

Influence of DNA technology

Garrod’s conception of biological individuality was confirmed with the advent of the sequencing of the human genome. Finally the subtle relationship between inheritance, individuality and environment became apparent via the variations detected in DNA. In each patient’s DNA lies a script for how their bodies will change and become ill as well as how they will handle the assaults of the environment from the beginning of their life to its end. It is hoped that by knowing a patient’s genes that the biological strengths and weaknesses in respect to these assaults will be revealed and disease processes can be predicted before they have the opportunity to manifest. Although knowledge in this area is far from complete, there are already medical interventions based on this. More importantly, the physician, forewarned with this knowledge can guide the patient towards appropriate lifestyle changes to anticipate and mitigate disease processes.

See also

Lists


als:Diagnostik bg:Диагноза de:Diagnose eu:Diagnostiko it:Diagnosi he:אבחנה ms:Diagnosis nl:Diagnose no:Diagnose nn:Diagnose simple:Diagnosis sk:Diagnóza sr:Дијагностика sh:Dijagnoza fi:Lääketieteellinen diagnoosi sv:Diagnostik ta:அறுதியிடல்

Template:Jb1

Template:WikiDoc Sources

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Sumanth Khadke, MD[2], Ogechukwu Hannah Nnabude, MD


Overview

Compliance with avoidance is important. The key to avoidance is proper evaluation and detection of causative allergen. Wear appropriate clothing to protect against irritants at home and in a work environment. [1] [2]


Treatment

High-potency topical corticosteroids, e.g. clobetasol propionate 0.05% cream, may be used to reduce the inflammation. [3] As a general rule, high-potency corticosteroids should not be used on thin skin, e.g. face, genitals, intertriginous areas, to avoid the risk of skin atrophy. Antihistamines such as hydroxyzine and cetirizine are recommended to control pruritus. Systemic steroids are advised in severe cases but should be tapered gradually to prevent recurrences. Friction should be avoided as well as the use of soaps, perfumes, and dyes. Emollients are used for hydrating the skin. Tacrolimus ointment and pimecrolimus cream are immunomodulating drugs that inhibit calcineurin and are helpful in allergic contact dermatitis.



Reference

  1. Soltanipoor M, Kezic S, Sluiter JK, de Wit F, Bosma AL, van Asperen R; et al. (2019). “Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial”. Contact Dermatitis. 80 (6): 365–373. doi:10.1111/cod.13214. PMC 6593800 Check |pmc= value (help). PMID 30652317.
  2. Nedorost S (2018). “A diagnostic checklist for generalized dermatitis”. Clin Cosmet Investig Dermatol. 11: 545–549. doi:10.2147/CCID.S185357. PMC 6217130. PMID 30464569.
  3. Vernon HJ, Olsen EA (1990). “A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis”. J Am Acad Dermatol. 23 (5 Pt 1): 829–32. doi:10.1016/0190-9622(90)70297-u. PMID 2147698.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH